Atlas Trials

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Clinical trial NCT00081744 · COMPLETED

Trial details

NCT number
NCT00081744
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gram-Positive Bacterial InfectionsCross Infection
Start date
2002-11-01
Primary completion
2004-08-01
Enrollment
850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.